The Closed-Loop System Improved the Control of a Pregnant Patient with Type 1 Diabetes Mellitus
Objective. Closed-loop insulin systems represent a technological advance in diabetes management but have rarely been studied in pregnancy. We report a case of a patient with type 1 diabetes mellitus who was previously a user of the Paradigm VEO pump and then migrated to Medtronic 670G. Research Desi...
Saved in:
Published in | Case reports in endocrinology Vol. 2021; pp. 7310176 - 4 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Hindawi
2021
Hindawi Limited Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objective. Closed-loop insulin systems represent a technological advance in diabetes management but have rarely been studied in pregnancy. We report a case of a patient with type 1 diabetes mellitus who was previously a user of the Paradigm VEO pump and then migrated to Medtronic 670G. Research Design and Methods. We reviewed the case of a G1P0 patient with type 1 diabetes, treated with the Medtronic 670G system during pregnancy; a comparison with current literature was done. Results. The patient achieved improved glycemic control as measured by time spent in different ranges as follows: <70 mg/dL, 8–4% and 70–180 mg/dL, 83–94%. Secondary outcomes included reduction of stress, anxiety, fear of hypoglycemia, and the psychological burden related to the disease. There were no obstetric or neonatal complications. Conclusion. The Medtronic 670G closed-loop system was used safely in a pregnant woman; nevertheless, further research is needed to validate this system in this patient population. |
---|---|
Bibliography: | Academic Editor: Osamu Isozaki |
ISSN: | 2090-6501 2090-651X |
DOI: | 10.1155/2021/7310176 |